TRADING UPDATES: MP Evans plots payout growth; Pebble in profit swing
TRADING UPDATES: MP Evans plots payout growth; Pebble in profit swing
Read moreTRADING UPDATES: MP Evans plots payout growth; Pebble in profit swing
Read more(Sharecast News) - Pharmaceutical services company Ergomed reported a 26.5% increase in revenue in its full-year results on Tuesday, to £86.4m.
Read moreTRADING UPDATES: Manolete Sets Records; Ergomed Earnings Top Forecasts
Read moreIN BRIEF: Ergomed To Buy MS Clinical Services To Further US Expansion
Read more(Sharecast News) - The Mail on Sunday's Midas column recommended readers 'buy' shares of pharmacovigilance specialist Ergomed.
Read moreUK EARNINGS SUMMARY: Tremor Loss Widens, Expects Third-Quarter Profit
Read moreUK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read more(Sharecast News) - Specialised pharmaceutical services company Ergomed said on Tuesday that it had an "excellent" first half, with overall growth in revenue driven by continued demand for its services across the integrated business, despite the Covid-19 pandemic.
Read moreUK TRADING UPDATE SUMMARY: DP Eurasia Interim Sales Up On Turkey Rise
Read moreUK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets
Read more(Sharecast News) - Specialist pharmaceutical services company Ergomed said on Wednesday that it had a "good" first quarter, with "solid" overall growth in revenue.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreErgomed Enters Strategic Collaboration With Automation Anywhere
Read more(Sharecast News) - Specialised pharmaceutical services provider Ergomed announced on Monday that it is providing support for a clinical development programme for 'namilumab', a monoclonal antibody therapy targeting granulocyte-macrophage colony stimulating factor (GM-CSF), for the treatment of patients with rapidly worsening Covid-19 coronavirus symptoms.
Read more